[1]
Rocca, R.; Scionti, F.; Nadai, M.; Moraca, F.; Maruca, A.; Costa, G.; Catalano, R.; Juli, G.; Di Martino, M.T.; Ortuso, F.; Alcaro, S.; Tagliaferri, P.; Tassone, P.; Richter, S.N.; Artese, A. * Chromene Derivatives as Selective TERRA G‐Quadruplex RNA Binders with Antiproliferative Properties. Pharmaceuticals, 2022, 15, 548.
[2]
Alkhatib, M.; Salpini, R.; Carioti, L.; Ambrosio, F.A.; D’Anna, S.; Duca, L.; Costa, G.; Bellocchi, M.C.; Piermatteo, L.; Artese, A.; Santoro, M.M.; Alcaro, S.; Svicher, V.; Ceccherini-Silberstein, F. Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile. Microbiol. Spectr., 2022, 10, 2.
[3]
Alkhatib, M.; Svicher, V.; Salpini, R.; Ambrosio, F.A.; Bellocchi, M.C.; Carioti, L.; Piermatteo, L.; Scutari, R.; Costa, G.; Artese, A.; Alcaro, S.; Shafer, R.; Ceccherini-Silberstein, F. SARS-CoV-2 Variants and Their Relevant Mutational Profiles: Update Summer 2021. Microbiol. Spectr., 2021, 9, e0109621.
[4]
Salpini, R.; Alkhatib, M.; Costa, G.; Piermatteo, L.; Ambrosio, F.A.; Di Maio, V.C.; Scutari, R.; Duca, L.; Berno, G.; Fabeni, L.; Alcaro, S.; Ceccherini-Silberstein, F.; Artese, A.; Svicher, V. Key genetic elements, single and in clusters, underlying geographically dependent SARS-CoV-2 genetic adaptation and their impact on binding affinity for drugs and immune control. J. Antimicrob. Chemother., 2021, 76, 396-412.
[5]
Bagetta, D.; Maruca, A.; Lupia, A.; Mesiti, F.; Catalano, R.; Romeo, I.; Moraca, F.; Ambrosio, F.A.; Costa, G.; Artese, A.; Ortuso, F.; Alcaro, S.; Rocca, R. Mediterranean products as promising source of multi-target agents in the treatment of metabolic syndrome. Eur. J. Med. Chem., 2020, 186, 111903.
[6]
Rocca, R.; Palazzesi, F.; Amato, J.; Costa, G.; Ortuso, F.; Pagano, B.; Randazzo, A.; Novellino, E.; Alcaro, S.; Moraca, F.; Artese, A. Folding intermediate states of the parallel human telomeric G-quadruplex DNA explored using Well-Tempered Metadynamics. Sci. Rep., 2020, 10, 3176.
[7]
Maruca, A.; Lanzillotta, D.; Rocca, R.; Lupia, A.; Costa, G.; Catalano, R.; Moraca, F.; Gaudio, E.; Ortuso, F.; Artese, A.; Trapasso, F.; Alcaro, S. Multi-Targeting Bioactive Compounds Extracted from Essential Oils as Kinase Inhibitors. Molecules, 2020, 25, 2174.
[8]
Costa, G.; Maruca, A.; Rocca, R.; Ambrosio, F.A.; Berrino, E.; Carta, F.; Mesiti, F.; Salatino, A.; Lanzillotta, D.; Trapasso, F.; Artese, A.; Alcaro, S.; Supuran, C.T. In silico identification and biological evaluation of antioxidant food components endowed with IX and XII hCA inhibition. Antioxidants, 2020, 9, 1-13, 775.
[9]
Artese, A.; Svicher, V.; Costa, G.; Salpini, R.; Di Maio, V.C.; Alkhatib, M.; Ambrosio, F.A.; Santoro, M.M.; Assaraf, Y.G.; Alcaro, S.; Ceccherini-Silberstein, F. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses. Drug Resist. Updat., 2020, 53, 100721.
[10]
Maruca, A.; Rocca, R.; Catalano, R.; Mesiti, F.; Costa, G.; Lanzillotta, D.; Salatino, A.; Ortuso, F.; Trapasso, F.; Alcaro, S.; Artese, A. Natural products extracted from fungal species as new potential anti-cancer drugs: A structure-based drug repurposing approach targeting HDAC7. Molecules, 2020, 25, 524.
Related Books
Science of Spices and Culinary Herbs - Latest Laboratory, Pre-clinical, and Clinical Studies
Frontiers in Natural Product Chemistry
Therapeutic Use of Plant Secondary Metabolites
Therapeutic Implications of Natural Bioactive Compounds
Frontiers in Bioactive Compounds
Frontiers in Natural Product Chemistry
Frontiers in Natural Product Chemistry
Science of Spices and Culinary Herbs - Latest Laboratory, Pre-clinical, and Clinical Studies
Frontiers in Natural Product Chemistry
Frontiers in Natural Product Chemistry
